Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.
about
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of lifeEfficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trialsComparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE studyLong-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designsFactors associated with medication adherence among patients with schizophrenia in Mekelle, Northern EthiopiaDoes adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic ReviewLong-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.Clinical predictors of therapeutic response to antipsychotics in schizophreniaMeasuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.Antipsychotic treatment and mortality in schizophrenia.Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.Feedback on SMS reminders to encourage adherence among patients taking antipsychotic medication: a cross-sectional survey nested within a randomised trial.Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort StudyValidation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience.Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.Use of coercive measures in mental health practice and its impact on outcome: a critical review.Tackling nonadherence in psychiatric disorders: current opinion.Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.Glutamatergic agents for schizophrenia: current evidence and perspectives.Determinants of adherence to treatment in first-episode psychosis: a comprehensive review.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up studyFrequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Three-month paliperidone palmitate - a new treatment option for schizophrenia.Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.Adherence to Medication Regimen in Patients with Severe and Chronic Psychiatric Disorders: A Qualitative Study.Antipsychotic combinations in schizophrenia.Routine quality care assessment of schizophrenic disorders using information systems.Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.Adherence to Antipsychotic Drug Measured by an Arabic Version of Morisky Scale.From compliance to adherence: Changing views, changing concepts.Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia.The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit.
P2860
Q26752965-C324A37A-8341-4514-9653-ECA04FE3C31CQ26781173-27848CE2-C6BD-4FB5-BBD6-FB7D872F8427Q27320151-8929C3F0-140E-4A31-A00B-DBB59EC0AC41Q28085407-EAE4E46C-4D11-4A8B-A8D6-4F484786A602Q28545127-A9A93EBD-5403-45AB-9251-32C9D718CF74Q30317036-C64199F6-E179-4712-A12F-EBC36B81D24CQ33695789-BA4D57E2-A345-464F-B38B-9F67C10183ECQ33802918-945B24DE-CBE5-4D7E-BC29-445EDC122F55Q34436401-A08B1F0C-5253-449F-8601-F838ACAFC986Q35109168-428B7357-0177-49C4-AD22-4ED8D1827C47Q35224289-8EB6BEEB-87A9-4C06-A1BC-61D158DC5FBEQ35369872-F83343FA-6A5A-43E5-8519-0082B4554FFAQ35607623-E9EA3316-08F4-4C13-A6DF-281553CD1453Q36302773-4AB07F55-6776-4347-BB19-211D5104E617Q36417435-4726885B-200D-478B-A5F0-F4F915503E34Q37185607-2E78DBCD-61A0-4769-964E-7F807CB8626FQ37441407-5F414D6F-BD03-4FA3-8AF6-FB103A7C480FQ38175069-95718FFA-FF51-4A69-85F9-1A470F8531C6Q38223376-756D9D01-AED7-409E-B5B8-457292ED6D9EQ38258128-E95C42C9-45B4-493C-89AC-190E67FB560BQ38444551-FABC5D55-9CFF-4E60-901D-B69E20086E32Q38462271-FBB353FE-7A4E-4251-A04F-C05A0CAEE93EQ38570636-CF162592-4A8B-4910-A099-C62C9520CBF1Q38613680-322BEE96-E387-44FE-9ACE-E15D148F132AQ38641789-A0B583A5-A10F-4750-9D2B-293AC6352746Q38659006-216A79CE-D424-40D3-868A-C3C86F4874C4Q38840088-0B700037-19A1-46B0-9E6D-605712C9920FQ38851123-26208A8C-54A4-452D-9A3C-537695828C04Q38851847-36977FEC-5A4A-42BC-8537-1D15AAAE6BBFQ38970065-AE20FAFE-7E05-46D8-84BC-57D626F07DE0Q39145621-0E56B7EB-C92A-48CB-8C97-EB8D1696B231Q39348889-2F861CD9-751B-4175-9620-9AED406EEA29Q39437386-9038D1D8-8B86-4AEB-A26F-B03F2E48410BQ39745540-D99E9720-0EF8-44D3-B127-51BBA42FE9B3Q42374864-48EF2EEB-733C-4290-8A52-BCF81ED68BA6Q44010252-A7149570-7C81-43EB-88D6-69B499CA6EBCQ44722660-2E16BDD1-21F1-44D5-A044-5A9C79D556D3Q47143480-719A26AF-1774-4D42-B502-A40BD9E0159CQ47154075-6EDE023E-8F0B-4EA5-8AFF-2EEFCFCC11E3Q47431234-B154FE26-5D26-426B-92AA-A7EB4B97C9A4
P2860
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-adherence to medication in ...... ors and management strategies.
@en
Non-adherence to medication in ...... ors and management strategies.
@nl
type
label
Non-adherence to medication in ...... ors and management strategies.
@en
Non-adherence to medication in ...... ors and management strategies.
@nl
prefLabel
Non-adherence to medication in ...... ors and management strategies.
@en
Non-adherence to medication in ...... ors and management strategies.
@nl
P2860
P921
P356
P1433
P1476
Non-adherence to medication in ...... ors and management strategies.
@en
P2093
Christoph U Correll
Taishiro Kishimoto
P2860
P304
P356
10.1002/WPS.20060
P407
P50
P577
2013-10-01T00:00:00Z